Search: Brian Wamhoff
October 17, 2017
Charlottesville biotechnology company HemoShear Therapeutics could receive over $470 million from a new partnership with Takeda Pharmaceutical Company, Asia’s largest pharmaceutical firm. Takeda, headquartered in Japan, will have exclusive access to HemoShear’s proprietary platform for modeling diseases in extracted human tissue to discover and develop new drugs for ...
The Virginia Department of Education